You are here

atezolizumab

FDA approves Roche therapy for bladder cancer

Marketwatch

Thu, 05/19/16 - 09:55 am

Roche Sees Its First Cancer Immunotherapy Winning U.S. Nod Soon

Bloomberg

Tue, 04/19/16 - 09:51 am

cancer immunotherapy

J&J joins up with Genentech for a pair of atezo/Darzalex combo cancer studies

Fierce Biotech

Tue, 03/22/16 - 04:06 pm

You'll Never Guess Which Pharma Likely Owns 40% of 2016's New Blockbusters

Motley Fool

Sat, 03/19/16 - 02:41 pm

Roche, Kite Pharma sign CAR-T and PD-L1 combo deal

Fierce Biotech

Fri, 03/18/16 - 11:00 am

Roche's new PD-L1 bladder cancer drug could be on the market by September

Fierce Biotech

Tue, 03/15/16 - 10:35 pm

Roche's star immunotherapy posts positive results in bladder cancer

Fierce Biotech

Sat, 01/9/16 - 10:36 am

Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'

Fierce Biotech

Fri, 12/11/15 - 11:31 am

triple negative breast cancer

5 Reasons Roche Thinks It Can Outclass the Competition

Motley Fool

Fri, 11/13/15 - 04:23 pm

dry macular degeneration

Roche says new drug shows benefits in lung, bladder cancer tests

Yahoo/Reuters

Sun, 09/27/15 - 08:47 pm

New data expected at lung-cancer conference on experimental drug combos

Medical Marketing and Media

Fri, 09/4/15 - 09:01 am

Bristol-Myers Squibb

Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo'

Fierce Biotech

Mon, 08/17/15 - 08:10 am

non-small cell lung cancer

anti-PD-1 immunotherapy

Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezo

Fierce Biotech

Mon, 07/13/15 - 09:49 am

Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab

Yahoo

Tue, 06/2/15 - 09:15 am

triple negative breast cancer

Talimogene Laherparepvec

colorectal cancer

Genentech's PD-L1 breakthrough star 'atezo' positioned to vault ahead on cancer

Fierce Biotech

Sun, 05/31/15 - 11:15 am